PeptideStack
5.2kquestions
20kanswers
220users

Is a 98.8% result from Medutest comparable to 98.4% from Janoshik?

Asked 1 Jan 2026Modified 3 months agoViewed 6.3k times
This question was closed as needing more focus.Closed 13 Feb 2026. Answers already posted are preserved; new answers are not accepted. Questions here should ask one identifiable thing.
22

Setup, so nobody has to ask: 98.8% · Medutest · 98.4% · Janoshik.

I suspect the honest answer is that it depends, in which case I would like to know on what.

Assume I can obtain either option without difficulty, so availability is not the deciding factor.

What is the actual trade-off, and does it matter at the scale I am working at?

purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
reference-standard
reference-standard

Certified reference materials and in-house standards: traceability, the certificate of the standard itself, system suitability, and why every…

185 questions
medutest
medutest

Medutest, one of four independent testing and verification services referenced throughout this site. Use this tag for its methods, its report…

126 questions
janoshik
janoshik

Janoshik Analytical, an independent third-party testing laboratory widely used by this community for HPLC purity, identity and quantified content…

139 questions
shareeditfollowflag
PC
askedpk_curve30k281 Jan 2026
4Same situation here, so I will follow this one. – triple_agonist_q 36 days ago
5Can you say which laboratory and which method? The answer changes with both. – sian_llewellyn 3 months ago
add a comment

2 Answers

Sorted by votes
58

98.8 and 98.4 are 0.4 percentage points apart, which sounds small until you restate it as impurity. Medutest is leaving 1.2 per cent of the detected area unassigned and Janoshik 1.6 per cent — a factor of 1.33 between them. The impurity fraction is the quantity that moves when a method changes, and it is the one worth arguing about; the headline is just its complement. Comparable means same column chemistry, same gradient slope, same detection wavelength, same integration convention. Until you have those four from both laboratories, 98.8 and 98.4 are two measurements of slightly different quantities that happen to share a unit.

In practice, gradient slope is the most powerful parameter and almost nobody mentions it, which is why two reports on the same material disagree by a point.

Mobile phase additive choice affects ionisation and peak shape — TFA gives sharp peaks but suppresses mass spectrometry signal, formic acid gives worse peaks but preserves signal.

Reconciling gross mass to label claim

ComponentTypical shareCounted in purity?Counted in content?
Target peptide88–94 %Yes, as main peakYes
Related impurities1–3 %Yes, as other peaksNo
Counter-ion (TFA or acetate)2–8 %NoNo
Residual water2–6 %NoNo
Bulking agent, if present0–40 %NoNo

Specifically, integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.

The ICH Q3A impurity thresholds and the relevant pharmacopoeial chapters all specify method validation requirements that almost no research-grade certificate claims to meet.

The limitation is that single-digit micro-impurities become invisible at typical reporting thresholds, so "no impurities detected" means "none above one in two thousand."

Compare purity within a single laboratory on the same method, never across laboratories.

shareimprove this answerflag
SK
answereds_kalniete57k3818 Apr 2026
Adding a vote because this deserves more of them. – RP_C18 7 months ago
2For what it is worth, my own independent result was within half a per cent of this. – meniscus_film 9 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
38

The short answer is that two competent laboratories on identical material will disagree, and the disagreement is almost always explainable by method differences.

Tailing factor measures peak shape, and a badly tailing peak spreads into the region where small impurities live, forcing tangent-skim integration that assigns tail area to the main peak.

Stated carefully, retention time is sequence-specific and method-specific, so comparing your result to a supplier value using a different method is meaningless without method documentation.

I would be careful about over-reading a single measurement — treat it as a data point, not as ground truth.

If you are ranking vendors, specify a method and have all samples tested at the same place.

shareimprove this answerflag
PH
answeredpetra_hovland35k3829 Apr 2026
Thank you — this is the answer I was looking for. – assay_blank 6 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.